According to the concept that rheumatoid arthritis (RA) develops across different phases long before the onset of clinical arthritis, studies for better characterisation and monitoring of risk factors for RA are of high importance. This kind of studies require the enrolment of individuals at risk for developing RA that are longitudinally and prospectively followed up. Dataset of clinical, patient-reported and laboratory / immunological variables will be used for clarifying the symptom burden of people at-risk, evaluate the relevance of PROs in monitoring and/or predicting RA development.
Project LeadP Studenic
The results of this study will provide a better characterisation of the restrictions in life and symptom burden in people with joint pain at‐risk for RA. It will provide a comprehensive overview of the ability of clinical and patient‐reported outcomes in monitoring at‐risk individuals and to detect symptom changes due to interventions. This will ultimately lead to earlier diagnosis, access to treatment and more profound evidence‐based information on the risk for developing RA.